Analyst Ratings for Legand Biotech Corp. (LEGN)
LEGN Rating Summary
LEGN Price Target Summary
- Highest: $75.00 (BTIG)
- Lowest: $53.00 (Barclays)
- Average: $63.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$63.14 (+52.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/15/2022 | Barclays | Gena Wang | New Coverage | Overweight (N/A) |
53.00 (N/A) |
31.02 (41.52) |
33.85% | Details |
1/31/2022 | Morgan Stanley » Updated 3/7/2022 |
Matthew Harrison | Upgrade | Overweight (Equalweight) |
55.00 (51.00) |
35.78 (41.52) |
16.04% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |